- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
News 214 results
In the News · Source: Law360
In the News · Source: Law360
In the News · Source: Bloomberg Law
February 19, 2025
Ashley Parrish counsels the American Clinical Laboratory before a Texas federal court in a dispute with the FDA over the supervision of laboratory developed tests
In the News · Source: Law360
In the News · Source: Medtech Insight
February 6, 2025
Eric Henry explains the impact of the FDA's recent communication freeze blocking participation in international standards development groups
In the News · Source: Medtech Insight
January 23, 2025
Lauren Roth discusses how states are navigating AI compliance and regulations
Press Release
January 15, 2025
Lauren Roth, Former Leader of FDA’s Office of Policy, Joins King & Spalding’s FDA and Life Sciences Team
In the News · Source: Law360, Bloomberg Law, Reuters, POLITICO Influence, POLITICO Playbook, Thomson Reuters Westlaw Today, Attorney at Law Magazine, JDJournal, The Daily Docket and The National Law Journal
January 15, 2025
Lauren Roth, former U.S. Food and Drug Administration Associate Commissioner for Policy, joins the firm’s FDA and Life Sciences team in Washington, D.C.
In the News · Source: Pink Sheet
January 7, 2025
Lisa Dwyer discusses FDA’s final SIUU Guidance regarding off-label uses
In the News · Source: FDA Watch
In the News · Source: Law.com
December 27, 2024
K&S recognized for winning three Litigators of the Week in 2024, which places us in the top 3 of firms
In the News · Source: Law360 Healthcare Authority
December 17, 2024
Lisa Dwyer discuses FDA untitled letter trends regarding drug advertising and promotion